Timothy Lewis Cannon

机构：Inova Health System, Inova Fairfax Hospital, Virginia Cancer Institute, Inova Design Solutions (United Kingdom) · ORCID：0000-0001-5033-3071

发表论文 119 篇 · 总被引 5271 次 · h-index 24

代表论文

• Advanced adenomas among young endurance runners: A prospective hypothesis-generating prevalence study (2026 · Cancer Epidemiology · 被引 3)
• The ADAPT learning cancer treatment system: ARPA-H’s initiative to revolutionize cancer therapy (2026 · Cancer Cell · 被引 1)
• Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program (2026 · Cancer Cell · 被引 1)
• Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated Toxicities (2025 · Cancer Research Communications · 被引 1)
• Author response to “Physical activity – Even at high volumes – Is associated with a lower risk of colon cancer” by Erika Rees-Punia and Alpa V. Patel (2026 · Cancer Epidemiology)
• Atezolizumab (A) plus pertuzumab/trastuzumab/hyaluronidase (PHESGO) in patients (pts) with solid tumors with ERBB2 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. (2026 · Journal of Clinical Oncology)